361 related articles for article (PubMed ID: 29635941)
1. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.
Munkhaugen J; Otterstad JE; Dammen T; Gjertsen E; Moum T; Husebye E; Gullestad L
Eur J Prev Cardiol; 2018 Jun; 25(9):923-931. PubMed ID: 29635941
[TBL] [Abstract][Full Text] [Related]
2. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
3. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
4. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
Pokharel Y; Sharma PP; Qintar M; Lu Y; Tang Y; Jones P; Dreyer RP; Spertus JA
Atherosclerosis; 2017 Nov; 266():16-23. PubMed ID: 28946036
[TBL] [Abstract][Full Text] [Related]
7. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
9. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
10. Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.
Storey BC; Staplin N; Haynes R; Reith C; Emberson J; Herrington WG; Wheeler DC; Walker R; Fellström B; Wanner C; Landray MJ; Baigent C;
Kidney Int; 2018 Apr; 93(4):1000-1007. PubMed ID: 29146277
[TBL] [Abstract][Full Text] [Related]
11. Baseline levels of serum high sensitivity C reactive protein and lipids in predicting the residual risk of cardiovascular events in Chinese population with stable coronary artery disease: a prospective cohort study.
Dai W; Zhang Z; Zhao S
Lipids Health Dis; 2018 Dec; 17(1):273. PubMed ID: 30509306
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
13. [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention].
Chen RZ; Liu C; Zhou P; Tan Y; Sheng ZX; Li JN; Zhou JY; Wu Y; Yang YM; Song L; Zhao HJ; Yan HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):359-366. PubMed ID: 32450651
[No Abstract] [Full Text] [Related]
14. Prevalence and predictors of elevated high-sensitivity C-reactive protein in post-myocardial infarction patients: Insights from the VIRGO and TRIUMPH registries.
Qintar M; Sharma PP; Pokharel Y; Tang Y; Lu Y; Jones P; Dreyer RP; Spertus JA
Clin Cardiol; 2017 Dec; 40(12):1205-1211. PubMed ID: 29247528
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
16. High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome.
Fang M; Qian Q; Zhao Z; Zhu L; Su J; Li X
Int Heart J; 2018 Mar; 59(2):300-306. PubMed ID: 29479010
[TBL] [Abstract][Full Text] [Related]
17. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
[TBL] [Abstract][Full Text] [Related]
18. The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.
Mo J; Chen Z; Xu J; Wang A; Meng X; Zhao X; Li H; Wu S; Wang Y
Aging (Albany NY); 2020 Jun; 12(12):11990-12001. PubMed ID: 32544081
[TBL] [Abstract][Full Text] [Related]
19. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
